Apricot Capital
Overview
Apricot: a fruit that is small, yet packs a powerful punch. This is reflective of how we are like as a team – compact, nimble, and highly efficacious. Apart from these qualities, we also pride ourselv…
Investment Focus
- Innovative biotech, medtech, and life science companies addressing critical unmet global clinical needs
- Early- and growth-stage companies with strong potential for global expansion
- Entrepreneurs with a burning desire to make a difference and an authentic vision
Portfolio Companies
Reach Apricot Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Apricot Capital
What sectors does Apricot Capital invest in?
Apricot Capital invests in Healthcare, Artificial Intelligence, Pharmaceuticals, Medical Devices, Diagnostics and Biotech, and is based in Pasir Panjang Road, Singapore. Apricot Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Apricot Capital invest at?
Apricot Capital backs companies at Early Stage and Growth, writing cheques of 1M - 50M.
Which regions does Apricot Capital invest in?
Apricot Capital invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Apricot Capital invested in?
Apricot Capital's portfolio includes Ambrx, GenFleet, Akeso, Inc., Argo Biopharma, Shengsheng, Vivatides, Excalipoint and QL Biopharm.
How do I contact Apricot Capital?
Apricot Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
